If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDoric Nimrod 2 Regulatory News (DNA2)

Share Price Information for Doric Nimrod 2 (DNA2)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 119.00
Bid: 118.00
Ask: 120.00
Change: 0.00 (0.00%)
Spread: 2.00 (1.695%)
Open: 119.00
High: 119.00
Low: 119.00
Prev. Close: 119.00
DNA2 Live PriceLast checked at -
Doric Nimrod Air Two is an Investment Trust

To obtain income returns and a capital return for its shareholders by acquiring, leasing and then selling aircraft.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of the second aircraft

2 Dec 2011 17:15

RNS Number : 2979T
Doric Nimrod Air Two Limited
02 December 2011
 



THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR PUBLICATION, RELEASE, OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN, OR INTO, THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR ANY JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR ANY JURISDICTION IN WHICH SUCH AN OFFER OR SOLICITATION IS UNLAWFUL.

DORIC NIMROD AIR TWO LIMITED

Acquisition of the second aircraft

2 December 2011

 

Doric Nimrod Air Two Limited (the "Company") is pleased to announce that its wholly owned subsidiary, MSN 090 Limited (the "Subsidiary"), has today acquired an Airbus A380-800 aircraft bearing manufacturer's serial number 090 (the "Aircraft") for the sum of US$234,000,000. The Aircraft was delivered to the Subsidiary today at the Airbus delivery centre in Hamburg, Germany.

 

In connection with the acquisition of the Aircraft, the Subsidiary drew down senior debt financing in accordance with a Loan Agreement entered into with a syndicate of lenders (led by Australia and New Zealand Banking Group Limited and Sumitomo Mitsui Banking Corporation) in the amount of US$ 146,865,575.00.

 

Upon delivery, the Subsidiary also entered into an Aircraft Operating Lease with Emirates airline ("Emirates") pursuant to which the Aircraft has been leased to Emirates for an initial term of 12 years, with fixed lease rentals for the duration. The debt portion of the funding, which has been advanced under the same interest rate fixing methodology, will fully amortise over the 12 year term of the Lease, leaving the aircraft unencumbered at the conclusion of the Lease.

 

About the Company

The Company is a Guernsey domiciled, limited liability company which listed on the Specialist Fund Market of the London Stock Exchange and the Channel Islands Stock Exchange on 14 July 2011 (LSE:DNA2).

The Company's investment objective is to obtain income returns and a capital return for its Shareholders by acquiring, leasing and then selling aircraft.

The Company will purchase three Airbus A380-800 aircraft, which it intends to lease to Emirates Airlines, the national carrier owned by the Investment Corporation of Dubai, based in Dubai, United Arab Emirates.

The Company will seek to provide investors with income and capital returns through investment in the assets.

Once the first asset, second asset and third asset have been acquired and leased, the Company will target a distribution to shareholders of 4.5 pence per share per quarter (amounting to a yearly distribution of 9% based on initial placing price of 200 pence per share).

 

 

For further information, please contact:

For administrative and company information:

Anson Fund Managers Limited

+44 (0) 1481 722260

 

For shareholder information:

Nimrod Capital LLP

Richard Bolchover

Marc Gordon

+44 (0) 20 3355 6855

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQLLFERFILFIIL
Date   Source Headline
11th Apr 20245:06 pmRNSQuarterly Factsheet
11th Apr 20245:04 pmRNSDividend Declaration
11th Jan 20244:19 pmRNSQuarterly Report
11th Jan 20244:18 pmRNSDividend Declaration
22nd Dec 202312:24 pmRNSHolding(s) in Company
18th Dec 20237:00 amRNSCOMPLETION PARTIAL COMPULSORY REDEMPTION & TVR
15th Dec 20232:43 pmRNSUnaudited Interim Financial Report
11th Dec 20237:00 amRNSPartial Compulsory Redemption of Shares
8th Dec 20237:00 amRNSResult of AGM
13th Nov 20233:45 pmRNSNotice of AGM
10th Oct 20234:45 pmRNSQuarterly Report
10th Oct 20234:44 pmRNSDividend Declaration
9th Oct 20237:00 amRNSSALE OF TWO ASSETS
31st Jul 20234:19 pmRNSResignation of a non-executive director
24th Jul 20235:41 pmRNSAnnual Financial Report
13th Jul 20234:57 pmRNSQuarterly Report
13th Jul 20234:57 pmRNSDividend Declaration
18th Apr 20237:00 amRNSDirectorate Change
13th Apr 20235:03 pmRNSQuarterly Report
13th Apr 20235:02 pmRNSDividend Declaration
6th Apr 20235:14 pmRNSMSN 110 REDELIVERY CONDITION
4th Apr 20237:00 amRNSDirectorate Change
14th Mar 202312:56 pmRNSMSN109 REDELIVERY CONDITION
16th Feb 20232:11 pmRNSMSN105, MSN106 and MSN107 Redelivery Condition
15th Feb 20237:00 amRNSChange in Board and Board Committee Composition
13th Jan 20234:58 pmRNSQuarterly Report
12th Jan 20235:19 pmRNSDividend Declaration
15th Dec 20225:24 pmRNSHalf-year Report
13th Dec 20229:34 amRNSDirector Declaration
12th Dec 202212:08 pmRNSResult of AGM
15th Nov 20224:44 pmRNSNotice of AGM
17th Oct 20225:28 pmRNSHolding(s) in Company
17th Oct 20225:05 pmRNSHolding(s) in Company
13th Oct 20225:18 pmRNSQuarterly Report
13th Oct 20225:18 pmRNSDividend Declaration
24th Aug 20225:24 pmRNSHolding(s) in Company
10th Aug 20225:41 pmRNSHolding(s) in Company
8th Aug 20225:20 pmRNSHolding(s) in Company
29th Jul 20226:25 pmRNSAnnual Financial Report
15th Jul 20223:27 pmRNSQuarterly Report
14th Jul 20224:26 pmRNSDividend Declaration
20th Apr 20221:37 pmRNSAsset Update: MSN090 Redelivery Condition
12th Apr 20225:15 pmRNSQuarterly Report
12th Apr 20224:49 pmRNSDividend Declaration
8th Mar 20222:39 pmRNSAsset Update: MSN077 Redelivery Condition
1st Mar 20222:35 pmRNSDirectorate Change
23rd Feb 20226:32 pmRNSHolding(s) in Company
13th Jan 20225:05 pmRNSDividend Declaration
13th Jan 20225:05 pmRNSQuarterly Report
21st Dec 202112:54 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.